What is NDC 70518-4600?

70518-4600 is the product NDC for Zonisamide, Zonisamide 25 mg/1 capsule, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zonisamide?

47 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zonisamide NDC 70518-4600 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4600Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4600Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4600-0	70518460000	100 POUCH in 1 BOX (70518-4600-0) / 1 CAPSULE in 1 POUCH (70518-4600-1)Marketed from Mar 31, 2026
70518-4600-2	70518460002	50 POUCH in 1 BOX (70518-4600-2) / 1 CAPSULE in 1 POUCH (70518-4600-1)Marketed from May 27, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zonisamide
Generic name (nonproprietary): zonisamide
Active ingredients: Zonisamide — 25 mg/1
Dosage form: Capsule
Route: Oral
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077651
Marketing start: Mar 31, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 70518-4600_52cfd84c-67da-2c6b-e063-6394a90a0c93SPL ID 52cfd84c-67da-2c6b-e063-6394a90a0c93SPL set ID 50bb1a0a-a66d-4a13-a456-a10c1b8c8e94RxCUI 403966UNII 459384H98V
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518460000 followed by a unit qualifier and the quantity

Package 70518-4600-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-4600

What is NDC 70518-4600?: 70518-4600 is the product NDC for Zonisamide, Zonisamide 25 mg/1 capsule, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zonisamide.
What is the active ingredient?: Zonisamide.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zonisamide?: 47 other product NDCs are listed under this name. See all Zonisamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zonisamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4349	70518-4349-00
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Direct_Rx	72189-624	72189-0624-72
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0392	80425-0392-0180425-0392-02
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0370	80425-0370-01
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3903	70518-3903-00
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Direct_Rx	72189-374	72189-0374-72
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Viona Pharmaceuticals Inc	72578-040	72578-0040-0172578-0040-05
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	Viona Pharmaceuticals Inc	72578-041	72578-0041-0172578-0041-05
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Viona Pharmaceuticals Inc	72578-042	72578-0042-0172578-0042-0572578-0042-10
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc	68788-4004	68788-4004-06

All 48 Zonisamide NDCs

Other NDCs under ANDA 077651

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077651
Product	Strength	Form · route	Labeler	Product NDC
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Proficient Rx LP	63187-583
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2798
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-129
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-128
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-130
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	BluePoint Laboratories	68001-242
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	BluePoint Laboratories	68001-243
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	BluePoint Laboratories	68001-244